Business Wire

ExaGrid, Hyper-Converged Secondary Storage for Backup Leader, Reports Record Q1 Bookings and Revenue for Q1-2018

Del

ExaGrid®, a leading provider of hyper-converged secondary storage for backup, today announced record Q1 bookings and revenue for Q1 2018. ExaGrid grew at a rate of 20% over the same quarter of the prior year, continuing its trend of progressive growth at a faster rate than that of the overall market and resulting market share gain. ExaGrid continues its up-market trajectory, attracting increasing numbers of enterprise customers with hundreds of terabytes to petabytes of data to be backed up.

“ExaGrid posted another record first quarter due to the company’s continued focus on execution of our up-market strategy. In parallel to this up-market progression, ExaGrid’s average selling price for initial system purchases continues to rise,” said Bill Andrews, CEO and President of ExaGrid.

In addition to record Q1 bookings and revenue, ExaGrid:

  • began shipping its EX63000E that scales to a 2PB full backup in a single system with an ingest rate of over 400TB per hour and supports a replicated second site with storage of up to 4PB for disaster recovery and long-term retention, making it the largest and fastest system on the market;
  • announced a new strategic alliance with HYCU for purpose-built support of Nutanix environments using VMware or AHV hypervisors; and
  • received recognition as a “finalist” for a Network Computing award and Storage Magazine’s Product of the Year.

“Backup data is growing at over 30% year-over-year in larger IT organizations. They are continuing to hit the wall with inline deduplication with scale-up storage architectures that result in slower backups, slower restores, and an ever expanding backup window,” Andrews said.

Unlike first generation deduplication solutions that were either built into a backup application media server or into a scale-up storage appliance, ExaGrid delivers the backup industry’s only true scale-out architecture with data deduplication. It provides hard-dollar savings and also improves backup and restore performance by combining zone-level deduplication, adaptive deduplication, global deduplication, and a unique landing zone.

As the market matures, customers are understanding the performance degradation that data deduplication can have on backup unless a solution is intentionally architected to prevent any such impact. All deduplication solutions reduce storage and WAN bandwidth to a degree, but only ExaGrid solves the three inherent compute problems to achieve faster backups, restores, and VM boots by leveraging its unique landing zone, adaptive deduplication, and scale-out architecture.

“First generation deduplication solutions can be cost prohibitive for backup storage and are also slow for backups, restores, and VM boots, which is why over 80% of ExaGrid’s newly-acquired customers are replacing Dell EMC Data Domain, HP StoreOnce, Commvault Deduplication, and the Veritas 5200/5300 series of appliances with ExaGrid,” said Andrews.

ExaGrid is the only second generation backup storage vendor that has eliminated the three compute challenges inherent to backup storage with data deduplication. All backup storage vendors reduce storage and bandwidth to varying degrees but provide slow ingest rates because they perform data deduplication ‘inline.’ In addition, because they only store deduplicated data, restore speeds and VM boots are also very slow. ExaGrid’s ingest rate is three times faster - and restores/VM boots are up to 20 times faster - than its closest competitor. Unlike the first generation vendors that only add capacity as data grows, ExaGrid appliances add compute with capacity, ensuring that the backup window remains fixed in length. Only ExaGrid uses a scale-out architecture with a unique loading zone, which holistically addresses all of the scalability and performance challenges of backup storage.

ExaGrid’s published customer success stories and enterprise stories number over 350, more than all other vendors in the space combined. These include a two-page narrative and customer quote, demonstrating how satisfied customers are with ExaGrid’s unique architectural approach, differentiated product, and unrivalled customer support. Customers consistently state that not only is the product best-in-class, but ‘it just works.’

About ExaGrid
ExaGrid provides hyper-converged secondary storage for backup with data deduplication, a unique landing zone, and scale-out architecture. ExaGrid’s landing zone provides for the fastest backups, restores, and instant VM recoveries. Its scale-out architecture includes full appliances in a scale-out system and ensures a fixed-length backup window as data grows, eliminating expensive forklift upgrades. Visit us at www.exagrid.com or on LinkedIn. See what ExaGrid customers have to say about their own ExaGrid experiences and why they now spend significantly less time on backup.

ExaGrid is a registered trademark of ExaGrid Systems, Inc. All other trademarks are the property of their respective holders.

Contact information

ExaGrid
Christine Murphy, 508-898-2872 x248
cmurphy@exagrid.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 13:30Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+

Asda Selects HCL Technologies to Help Drive IT Transformation21.9.2018 12:16Pressemelding

HCL Technologies (HCL), a leading global technology company, today announced that it has been selected to help drive IT transformation at the UK’s third-largest grocery retailer, Asda. The three-year application services contract will see HCL transform Asda’s IT Application Services with a new DevOps delivery model to drive data and analytics and support back-office applications through the full lifecycle of development, testing and support. HCL will also build a central data management platform to enable Asda to improve its insight and analytics capabilities. Asda operates more than 600 stores across the UK, employing over 135,000 people. Asda wanted to adopt a more agile approach towards application development and testing. This would allow the company to respond faster to business requirements and reduce time to market, while driving better user experience and satisfaction. HCL was selected due to its extensive expertise in successfully delivering similar large scale IT transformati

Ipsen Receives Positive CHMP Opinion for Cabometyx® (Cabozantinib) for the Second-line Treatment of Patients with Hepatocellular Carcinoma (HCC)21.9.2018 05:30Pressemelding

Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), provided a positive opinion for Cabometyx® (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have been previously treated with sorafenib. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for the European Union (EU). Alexandre Lebeaut, MD, Executive Vice President, R&D and Chief Scientific Officer, Ipsen, said: “The global burden of liver cancer is increasing and despite the recent introduction of new agents, it remains the second leading cause of cancer mortality worldwide. Following today’s positive CHMP opinion and if approved by the European Commission, Cabometyx ® as monotherapy will give patients with HCC a much-needed new oral therapeutic option.” Dr Lorenza Rimassa,

Quanergy Selected as Exclusive LiDAR Partner for VRCO21.9.2018 05:00Pressemelding

Quanergy Systems, Inc., a global leader in the design and development of solid state LiDAR sensors and smart sensing solutions, and VRCO, designer and manufacturer of the luxury high-end e-VTOL (electric Vertical Take-Off and Landing) craft, the NeoXcraft XP2, today announced that VRCO will exclusively use Quanergy’s S3 solid state LiDAR sensors in the testing and market release versions of the aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006036/en/ VRCO NeoXcraft XP2 with Quanergy S3 LiDAR Sensor (Graphic: Business Wire) The NeoXcraft XP2, which VRCO and the University of Derby unveiled in late 2017 and intend to launch in 2020, is a two-passenger e-VTOL high-speed land, air, and water capable craft. The craft can scan and memorize take-off locations and store the data for use on the next approach to the same location. Quanergy’s innovative S3 solid state LiDAR sensor will be used for downward and forward

Overseas Roadshow for the IAPH Guangzhou 2019 World Ports Conference Was Held in London21.9.2018 03:08Pressemelding

Overseas roadshow for the IAPH Guangzhou 2019 World Ports Conference was successfully held in Armourer's Hall, London, UK on September 20th. Ms. Yuan Yue, Deputy Director General of Guangzhou Port Authority, met with over 100 senior representatives from British ports, ship-owners, commodity traders, shipping & service companies, shipping public policy research institutes, and other representatives from the port and shipping industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006031/en/ Speech made by Lord Jeffrey Evans, Chairman of Maritime London (Photo: Business Wire) In her keynote speech, Ms. Yuan Yue said, “Guangzhou is the gateway city of South China and is known as the “Millennium Business Capital” and a popular destination for business and investment. At present, Guangzhou has attracted investors from over 130 countries. Nearly 300 of the world's top 500 companies have businesses and investment in Guangzho

AbuDhabi Dubai STOB Series 22 Investment Enters into Favorable Tender Offer Agreement with MINDOL HOLDINGS21.9.2018 01:00Pressemelding

AbuDhabi Dubai STOB Series 22 Investment Limited Partnership, hereafter AbuDhabi22, and MINDOL HOLDINGS LIMITED, hereafter MINDOL, listed on the Hong Kong-based Coinsuper exchange (https://www.coinsuper.com) have reached an agreement where AbuDhabi22 will acquire the minimum 33.3 percent holding for the MINDOL cryptocurrency (MIN, https://mindol.net) to be issued by MINDOL, via a tender offer (TOB). Implementation of the TOB will serve to strengthen the strategic partnership with MINDOL. Both companies expect that the AbuDhabi22 bid will greatly exceed any bids made via ordinary exchange channels. With a bid offering at a stable price, the TOB method was chosen for its strategic worth. The MINDOL business vision for 2019 sets a target for its cryptocurrency, from among the more than 2,000 types of cryptocurrencies currently available, to have a top-30 market capitalization. As a business that focuses on "the fusion of subculture and blockchain," they will develop an online game that ta